Login to Your Account

Annapurna in-licenses three Weill Cornell gene therapy programs

By Cormac Sheridan
Staff Writer

Tuesday, January 5, 2016

DUBLIN – Gene therapy pioneer Ron Crystal, of Weill Cornell Medical College, is deepening his involvement in Annapurna Therapeutics SAS (formerly AAVLife SAS), the French gene therapy firm he co-founded, by licensing to the company three development programs that are already under way at Weill Cornell's Department of Genetic Medicine.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription